Health News (Reuters)

FDA issues warning letters to companies selling kratom products

(Reuters) - The U.S. Food and Drug Administration said on Tuesday it issued warning letters to three companies that illegally marketed and distributed products containing the substance, kratom, which they claimed treat opioid addiction and withdrawal.

Two more die of Ebola in Congo, seven new cases confirmed

MBANDAKA, Democratic Republic of Congo (Reuters) - Two more people have died from Ebola and seven new cases were confirmed in Democratic Republic of Congo, authorities said on Tuesday, but resistance to some public guidance about preventing the disease was evident in a provincial capital.

Egg a day tied to lower risk of heart disease

(Reuters Health) - People who eat an egg just about every day may have a lower risk of heart attack and stroke than individuals who don't eat eggs at all, a large Chinese study suggests.

More U.S. kids overdosing on ADHD drugs

(Reuters Health) - The surge in U.S. kids taking medication for attention-deficit hyperactivity disorder (ADHD) is having an unintended side effect, a new study suggests: more children and teens are overdosing on these drugs.

Nabriva shares tumble as safety worries plague pneumonia drug

(Reuters) - Nabriva Therapeutics Plc's antibiotic drug to treat a common form of pneumonia met the main goal of a key clinical trial, but concerns over its side effects sent the drug developer's shares down 13 percent on Monday.

Congo begins giving experimental Ebola vaccine to medics

MBANDAKA, Democratic Republic of Congo (Reuters) - Congo began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday to tackle an outbreak of the virus believed to have killed 26 people since early April.

Strong grip may predict longer life at all ages

(Reuters Health) - Grip strength may be a better predictor of future health than some measurements doctors currently use to gauge risk, a large UK study suggests.

PM May challenges scientists to help transform Britain after Brexit

LONDON (Reuters) - Britain's prime minister challenged scientists on Monday to help diagnose cancer earlier and create zero-emission cars, trying to reboot an industrial strategy all but eclipsed by Brexit, while acknowledging Britain's reliance on foreign scientists.

Dova Pharma's blood disorder drug gets FDA approval

(Reuters) - The U.S Food and Drug Administration said on Monday it had approved Dova Pharmaceuticals Inc's drug to treat low blood platelet count in chronic liver disease (CLD) patients, who are scheduled to undergo a medical procedure.

Nabriva's pneumonia drug succeeds in late-stage study

(Reuters) - Nabriva Therapeutics Plc's pneumonia drug for adults met the main goal of a late-stage study, the company said on Monday, putting it on track to file a marketing application with U.S. regulators later this year.

AstraZeneca potassium drug finally approved, threatening Vifor

LONDON (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it strives to offset declining sales of older products.

Ebola preparedness much better now than for 2014 outbreak: WHO

GENEVA (Reuters) - The spread of Ebola to a major city in Democratic Republic of Congo is worrying but the outlook is much more optimistic than when a major outbreak was reported in West Africa in 2014, the head of the World Health Organization said on Monday.

Roche drug dramatically reduces bleeds in key hemophilia tests

LONDON (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position.

British PM May calls on health, tech sectors to work on cancer

LONDON (Reuters) - Prime Minister Theresa May will call on Britain's health service, charities and artificial intelligence sector to work together to better identify patients with the early stages of cancer and stop thousands dying each year.

Pages